Assessment of Anti-Coagulation Therapy on Patient With Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Contemporary data are lacking regarding the management of left ventricular thrombus (LVT) developed after ST segment elevation myocardial infarction
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Established ST segment elevation myocardial infarction within 7 days Left ventricular thrombus (LVT) is detected by either cardiac magnetic resonance (CMR) or TTE.
• Ongoing treatment with dual anti-platelet therapy according to ESC/AHA guidelines at the time of randomization
Locations
Other Locations
China
Jilin university
RECRUITING
Changchun
Contact Information
Primary
Mingyou Zhang
zmy@jlu.edu.cn
86-431-88782342
Backup
Zhaoxi Liu
86-431-88782342
Time Frame
Start Date: 2023-05-01
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 320
Treatments
Experimental: intervention
patient will receive dual antiplatelet therapy, the choose of p2Y12 inhibitor is at the discretion of the clinician. in addition the patient will receive rivaroxaban 15mg daily in addition to the dual antiplatelet therapy.
No_intervention: control
patient will receive dual antiplatelet therapy, the choose of p2Y12 inhibitor is at the discretion of the clinician.
Related Therapeutic Areas
Sponsors
Leads: Jilin University